Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.
MA Wainberg, O Kendall, N Gilmore - CMAJ: Canadian Medical …, 1988 - ncbi.nlm.nih.gov
Human immunodeficiency virus type 1 (HIV-1) has been clearly associated with a variety of
new illnesses, including profound immunodeficiency (acquired immune deficiency …
new illnesses, including profound immunodeficiency (acquired immune deficiency …
Human immunodeficiency virus
EA Emini, SD Putney - Vaccines, 1992 - Elsevier
Publisher Summary This chapter provides an overview on human immunodeficiency virus
(HIV). The syndrome is characterized by a severe immunodeficiency, manifested by the …
(HIV). The syndrome is characterized by a severe immunodeficiency, manifested by the …
Vaccines for the control of HIV/AIDS.
F Gotch, A Rutebemberwa, G Jones… - Vaccines for the …, 2000 - cabdirect.org
Vaccines for the control of HIV/AIDS. Cookies on CAB Direct Like most websites we use
cookies. This is to ensure that we give you the best experience possible. Continuing to use …
cookies. This is to ensure that we give you the best experience possible. Continuing to use …
Vaccines against human immunodeficiency virus--progress and prospects
NL Letvin - New England Journal of Medicine, 1993 - Mass Medical Soc
The frightening pace of the worldwide spread of the human immunodeficiency virus (HIV)
demands that priority be placed on the development of an effective vaccine1. Two distinct …
demands that priority be placed on the development of an effective vaccine1. Two distinct …
Vaccines directed against HIV: preventive and therapeutic strategies.
JO Kahn, DL Birx - AIDS clinical review, 1993 - europepmc.org
Vaccine therapy studies in HIV-seropositive volunteers over the next year should provide
additional insights into whether different vaccine viral strains (LAI, IIIB, MN, SF2), different …
additional insights into whether different vaccine viral strains (LAI, IIIB, MN, SF2), different …
Immunotherapy of human immunodeficiency virus infection
JW Hadden - Trends in pharmacological sciences, 1991 - cell.com
HIV infection and AIDS are complicated and expensive in terms of human suffering, amount
of care and financial cost. Like the treatment of cancer, palliation is necessary but difficult …
of care and financial cost. Like the treatment of cancer, palliation is necessary but difficult …
Strategies for developing vaccines against acquired immunodeficiency syndrome.
EM Zhou, RC Kennedy - Biochimica et Biophysica Acta, 1989 - europepmc.org
There exists an abundance of literature on the prospects for developing vaccines against the
etiologic viral agent of acquired immunodeficiency syndrome (AIDS). Excellent reviews from …
etiologic viral agent of acquired immunodeficiency syndrome (AIDS). Excellent reviews from …
Strategies for AIDS vaccines
EJ Stott, GC Schild - Journal of Antimicrobial Chemotherapy, 1996 - academic.oup.com
In the global AIDS epidemic, over half of all infections have occurred in people less than 25
years old resulting in profound social, economic and demographic consequences. Current …
years old resulting in profound social, economic and demographic consequences. Current …
Immunization programs and human immunodeficiency virus
JR La Montagne - Clinical Infectious Diseases, 1989 - academic.oup.com
The emergence of human immunodeficiency virus (HIV) in epidemic form has implications
for immunization programs. Infection with HIV, which is capable of infecting cells of the …
for immunization programs. Infection with HIV, which is capable of infecting cells of the …
Human immunodeficiency virus vaccines
DP Bolognesi - Advances in virus research, 1993 - Elsevier
Publisher Summary This chapter describes the progress in the development of a human
immunodeficiency virus (HIV) vaccine. It focuses principally on HIV, ranging from the …
immunodeficiency virus (HIV) vaccine. It focuses principally on HIV, ranging from the …